New Chinese guidelines for the treatment and evaluation of IgG4-related disease have been published, providing updated protocols for clinicians. These guidelines aim to enhance the understanding and management of this complex condition.
chinese guidelines for the treatment and evaluation of igg4 related disease 2026 edition
Original title: “[Chinese guidelines for the treatment and evaluation of IgG4-related disease (2026 edition)].”